Categories AlphaGraphs, Earnings, Health Care
REGN Earnings: Regeneron Pharma Q3 revenue, adj. profit increase
Healthcare firm Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported an increase in adjusted earnings and revenues for the third quarter of 2023.
September quarter revenues rose 15% year-over-year to $3.36 billion. Net product sales, which account for more than 50% of total revenues, edged down by 1%.
Adjusted earnings moved up 4% to $11.59 per share in Q3 from $11.14 per share in the same period of 2022. Unadjusted profit was $1.0 billion or $8.89 per share, compared to $1.32 billion or $11.66 per share last year.
“We have continued our momentum in the third quarter of 2023 with double-digit year-over-year revenue growth, driven by strong Dupixent and Libtayo performance, as well as strong initial uptake of EYLEA HD following its late August launch,” said the company’s CEO Leonard Schleifer.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key metrics from Biogen’s (BIIB) Q4 2024 earnings results
Biogen Inc. (NASDAQ: BIIB) reported its fourth quarter 2024 earnings results today. Total revenue increased 3% year-over-year to $2.5 billion. Net income attributable to Biogen Inc. was $266.8 million,
Important takeaways from Coca-Cola’s (KO) Q4 2024 earnings
The Coca-Cola Company (NYSE: KO) has wrapped up fiscal 2024 on an upbeat note, reporting stronger-than-expected results for the final quarter of the year. Encouraged by the growth in sales
Walt Disney (DIS): A look at the performance of the streaming business in 1Q25
Shares of The Walt Disney Company (NYSE: DIS) dropped 1% on Tuesday. The stock has gained 6% over the past three months. The company delivered top and bottom line growth